Q is effective for COVID-19. The probability that an ineffective treatment generated results as positive as the 145 studies to date is estimated to be 1 in 235 billion (p
Early treatment is most successful, with 100% of studies reporting a positive effect and an estimated reduction of 63% in the effect measured (death, hospitalization, etc.) using a random effects meta-analysis, RR 0.37 [0.29-0.47].
100% of Randomized Controlled Trials (RCTs) for early, PrEP, or PEP treatment report positive effects, the probability of this happening for an ineffective treatment is 0.001.
There is evidence of bias towards publishing negative results. 89% of prospective studies report positive effects, and only 74% of retrospective studies do.
Significantly more studies in North America report negative results compared to the rest of the world, p